MAPT and Alzheimer disease: Recent studies have suggested that the conjugation of AβOs can induce AD-like pathologies, including neuronal tau protein hyperphosphorylation28, oxidative stress29,30, synaptic degeneration and loss30,31, and inhibition of synaptic plasticity32, which may be central to insulin treatment involved in the pathogenesis of AD in T2DM patients.